eYantra Ventures raises Rs. 15 Crore through preferential issue; eyes global expansion

Hyderabad (Telangana) [India], January 17: eYantra Ventures Limited (BSE Code: 512099; eYantra) has completed fundraise of Rs.15 crore through preferential issue of equity shares, marking a pivotal step in its strategic growth journey. The capital will be used to scale operations and drive global expansion.

Key Highlights of the Preferential Issue:

  • Number of Shares: 1,87,500 equity shares
  • Issue Price: Rs 800 per share
  • Total Capital Raised: Rs. 15 crore

“We hereby inform you that the Board of Directors at its Meeting held today i.e., Friday, January 17th, 2025, has approved the allotment of 1,87,500 equity shares of the Company at an Issue Price of Rs. 800/- per share aggregating ₹15 crore through preferential allotment,” said the company in the exchange filing.

What does it mean for eYantra?
The funds raised through this preferential issue will be deployed in several key areas:

  1. Healthcare Investments: The capital will support the recent acquisition of a 60% stake in Neuro and Spine Associates Private Limited. This strategic investment enhances eYantra’s presence in the healthcare sector, diversifying its portfolio and opening new revenue streams.
  2. Scaling Branded Merchandising Solutions: eYantra plans to expand its branded merchandising solutions business, which is experiencing significant growth across India. These efforts aim to increase market penetration and revenue generation.
  3. Global Expansion of IT/ITES business: Building on its established operations, eYantra has recently launched its software services business in Dubai and is preparing to enter the United States. These expansions are set to capitalize on the growing demand for innovative software solutions, positioning eYantra as a global player in this domain.

About eYantra Ventures Limited:
eYantra Ventures Limited is a diversified enterprise with interests spanning across branded merchandising solutions, healthcare and IT/ITES. Committed to innovation and growth, the company’s strategic initiatives and global expansion underline its dedication to creating long-term value for its stakeholders.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Business

Automation Expo South 2025: South India’s Premier Event for Industrial Automation, AI and Robotics

Chennai (Tamil Nadu) [India], February 18:  With industries embracing automation, AI, and robotics at an unprecedented pace, Automation Expo South 2025 stands as the definitive platform to explore groundbreaking solutions shaping the future of manufacturing, industrial automation, and digital transformation. Taking place from 6th to 8th March 2025 at the Chennai Trade Centre, the event […]

Read More
Business

Abakkus Leads Rs. 175 Crore Funding in Stelmec Limited with Hem Securities Ltd. as Lead Advisor

New Delhi [India], February 18: Mumbai based Stelmec Limited, a three decade-old name synonymous with Electrical Power Products in India and a trusted partner to various State Owned and Private Power Utilities, has secured ₹175 crore from a consortium led by Abakkus Four2Eight Opportunities Fund. The transaction was facilitated, Hem Securities Ltd., who played a pivotal role in […]

Read More
Business

Giosun Healthcare Sets New Standards in Ayurvedic Wellness at IPLCM Expo 2025

New Delhi [India], February 17: Giosun Healthcare Private Limited, a leading innovator in herbal cosmetics, personal care, and nutraceuticals, made a significant impact at the International Private Label & Contract Manufacturing (IPLCM) Expo 2025 held at the Bombay Exhibition Centre. With a portfolio of over 700 natural wellness products, the company reaffirmed its dedication to […]

Read More